Breaking News, Collaborations & Alliances

Ono, BioFocus in Discovery Pact

Aims to discover targets in allergic diseases

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Galapagos NV and Ono Pharmaceutical have signed a collaboration agreement for the discovery of targets in the field of allergic diseases, including atopic dermatitis and bronchial asthma. Galapagos’ service division BioFocus will use its SilenceSelect platform to deliver validated targets to Ono. Ono aims to find modulators for these targets and generate new drug candidates. This marks the second collaboration between the companies. Financial details were not disclosed.   “We are delighted with ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters